Clinical Trial Details

MOST

Myelofibrosis and Essential Thrombocythemia Observational Study

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Cancer
Study Type: Interventional
Phase: Phase II
Study Start Date: 12/01/2016
Study Completion Date: 12/31/2021

The purpose of this prospective, longitudinal, noninterventional study is to describe clinical characteristics, evolution of disease burden, and treatment patterns in patients with select subcategories of essential thrombocythemia (ET) or myelofibrosis (MF).

NCT Number

NCT02953704

Principal Investigator(s)

John Wallmark, MD

Sponsor(s)

Incyte Corporation

Participant Eligibility

• Age: 18 - No Maximum
• Gender: Male, Female